LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

Search

Zoetis Inc

Suletud

SektorTervishoid

76.68 0.07

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

75

Max

78.63

Põhinäitajad

By Trading Economics

Sissetulek

-2M

601M

Müük

-125M

2.3B

P/E

Sektori keskmine

12.569

51.415

Aktsiakasum

1.53

Dividenditootlus

2.45

Kasumimarginaal

26.569

Töötajad

14,500

EBITDA

-6M

941M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+77.81% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.45%

2.34%

Järgmine tulemuste avaldamine

4. aug 2026

Järgmine dividendimakse kuupäev

2. juuni 2026

Järgmine aktsia dividendi kuupäev (ex-date)

17. juuli 2026

Turustatistika

By TradingEconomics

Turukapital

-15B

32B

Eelmine avamishind

76.61

Eelmine sulgemishind

76.68

Uudiste sentiment

By Acuity

54%

46%

269 / 346 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Zoetis Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. aug 2025, 11:06 UTC

Tulu

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5. aug 2025, 11:06 UTC

Tulu

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5. aug 2025, 11:05 UTC

Tulu

Zoetis 2Q Adj EPS $1.76 >ZTS

Võrdlus sarnastega

Hinnamuutus

Zoetis Inc Prognoos

Hinnasiht

By TipRanks

77.81% tõus

12 kuu keskmine prognoos

Keskmine 136.33 USD  77.81%

Kõrge 160 USD

Madal 99 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Zoetis Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

8

Osta

6

Hoia

0

Müü

Tehniline skoor

By Trading Central

152.58 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

269 / 346 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat